The participants attracted by high return on investment (ROI) are leading to market expansion. Also, investment by various other geographical regions in horse racing is driving the growth of this market. However, availability of alternatives to gambling such as online betting and the declining population of equine is limiting the growth of this market. The emerging sub segments in this market would provide growth opportunities in this market. The Asia-Pacific market may also serve as an emerging market, thereby providing growth opportunity to this market.
Global Equine Healthcare Market by Therapeutic Product Type
Based on therapeutic product types this market can be classified into equine therapeutics market and equine vaccines market. These have many other products including various vaccines, anti-bacterial, anti-viral anti-protozoal, laxatives and dopamine.
Global Equine Healthcare Market by Diagnostic Product Type
Based on diagnostic products types this market is classified into equine pregnancy and gestation diagnostic products and equine genotyping analysis products.
Global Equine Healthcare Market by Supplement Product Type
Based on its supplement product types this market is classified into equine performance supplements and equine protection supplements. The use of performance supplement is more, as it is used for enhancing the speed of the horse during races.
Global Equine Healthcare Market by Geography
Based on geography this market can be classified into North America, Europe, Asia-Pacific and LAMEA. This market is expected to grow in Asia-Pacific regions due to increase in investment on betting and horse riding.
The key companies in the report include Merck Animal Health, Boehringer Ingelheim Vetmedica, Affymetrix, Elanco Animal Heath, Zoetis (Pfizer Animal Health), Equine Health U.K., and Equine Orthotics and Prosthetics. These companies are focusing on developing products for enhancing equine health as the population of equine is declining.
High Level Analysis
The global equine healthcare market is an emerging field of pharmaceuticals. The market is facing challenges due to stringent regulations. However, these regulations are strategically dealt in this report and more emphasis is given on the commercial polices available for these products. The report describes the present industrial scenario with the help of Porter’s five forces model. The bargaining power of buyers is high due to higher number of suppliers present in the market. This industry witnesses competition due to numerous players available for the same product. The market dynamics show that the impact of drivers is more in the market compared to the restraints
Estimations are made by considering current market scenario and future potential for the period of 2013-2020
Intelligence from key market segments through top investment pockets would help in providing strategic assistance to decision makers
The growth drivers and restraints are described to know the factors, which would affect the growth of this market
The report deals with the opportunities, which would fuel the growth of this market
The key market players and strategies adopted by them are dealt to give an insight on top contenders in the market
Porter’s five forces and SWOT analysis discussed would help in making strategic decisions
The global cell surface marker market is segmented on the basis of
* This report will be delivered in 12 Business Days. *